Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Efficacy of Saquinavir and Lopinavir/Ritonavir in ARV-naive HIV-1 Patients
NCT00400738Phase 2Completed
- Sponsor
- HIV-NAT
- Start
- Mar 2004
- Primary completion
- Dec 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised trial of saquinavir, lopinavir and ritonavir in human immunodeficiency virus infection (HIV) (4 arms), sponsored by HIV-NAT. Primary endpoint: Pharmacokinetics of lopinavir/ritonavir and saquinavir at 1 year. Started Mar 2004; status: completed.
02
Drugs
saquinavirlopinavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00400738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00400738.